Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?
Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come.
Society Pass currently has...
Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
New Report Coming, Sign up to our Newsletter for Priority Notification.
Absolutely banging numbers, we view Smart...
Adding Principal Solar (PSWW) to Watch List.
LIVE QUOTE
Principal Solar Website
Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.
Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....
Smart for Life (SMFL) $0.43 on Track to Close Pending Acquisition of Ceautamed Worldwide.
Has Smart for Life Found a Base at $0.45? Market Action Aside, We Think So. Report Out Monday.
Dalrada (DFCO) Removes Shell Company Status.
LIVE QUOTE
SAN DIEGO, Nov. 6, 2020
SAN DIEGO , Nov. 6,...
Dennis Nguyen, Founder/Chairman/CEO of Nasdaq-listed Society Pass Inc. (Nasdaq: SOPA) to Speak at NXT...
SINGAPORE, Feb. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Society Pass Incorporated ("SoPa”) ( Nasdaq: SOPA ), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce...
Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds Appeal for Both...
Press Release:
February 28, 2023 07:30 ET | Source: Society Pass Incorporated
New York,...
True Nature|Mitesco President & COO, Julie Smith Interview.
Julie R. Smith is a seasoned senior executive...
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
